Trial Profile
A pharmacokinetic and pharmacodynamic study of nebivolol in healthy volunteers and patients with chronic kidney disease undergoing haemodialysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Renal failure
- Focus Pharmacodynamics; Pharmacokinetics
- 10 Mar 2016 New trial record
- 23 Feb 2016 Results published in the British Journal of Clinical Pharmacology